Lixia Huang
- Biomaterials top 5%
- Electrospun Nanofibers in Biomedical Applications 4
- Nanoparticle-Based Drug Delivery 3
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 3
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 3
-
- Cancer Genomics and Diagnostics 4
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 3
-
- RNA modifications and cancer 3
- Journals
- PLoS ONE (3 papers)Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaCanadaSwitzerland
In The Last Decade
Lixia Huang
61 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 132
- Biomaterials 199
- Molecular Medicine 72
- Oncology 259
- Cancer Research 127
- Immunology 140
Countries citing papers authored by Lixia Huang
This map shows the geographic impact of Lixia Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Huang more than expected).
Fields of papers citing papers by Lixia Huang
This network shows the impact of papers produced by Lixia Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Huang. The network helps show where Lixia Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lixia Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 0 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 14 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 7 | |
| 14 | 2019 | 5 | |
| 15 | 2018 | 84 | |
| 16 | 2017 | 18 | |
| 17 | 2015 | 39 | |
| 18 | Combined neurolytic block of celiac and superior hypogastric plexuses for incapacitating upper abdominal cancer pain. | 2014 | 7 |
| 19 | [Live cell fluorescent imaging and cytotoxicity assessment of pH fluorescent probe based on styrylcyanine dyes]. | 2014 | 1 |
| 20 | 2013 | 32 |
About Lixia Huang
Lixia Huang is a scholar working on Molecular Medicine, Biomaterials and Oncology, having authored 66 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer Genomics and Diagnostics (4 papers), Electrospun Nanofibers in Biomedical Applications (4 papers), Antibiotic Resistance in Bacteria (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), RNA modifications and cancer (3 papers), Nanoparticle-Based Drug Delivery (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Biomaterials (199 citations), Molecular Medicine (72 citations) and Oncology (259 citations). Lixia Huang has collaborated with scholars based in China, Canada and Switzerland. Frequent co-authors include Guang Yang, Lin Xiao, Yanbin Zhou, Shaoli Li, Jincui Gu, Xiaoxian Cui, Ziying Lin, Ahmed M. E. Abdalla, Baomo Liu and Mario Gauthier. Their work appears in journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.